Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29476 - 29500 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	CENPF	1063	downregulated	decitabine results in decreased expression of CENPF mRNA	1q41	A21913
Decitabine	Approved Investigational	CEP57	9702	downregulated	decitabine results in decreased expression of CEP57 mRNA	11q21	A21913
Decitabine	Approved Investigational	CHD8	57680	upregulated	decitabine results in increased expression of CHD8 mRNA	14q11.2	A21949
Decitabine	Approved Investigational	CHFR	55743	upregulated	decitabine results in increased expression of CHFR mRNA	12q24.33	A21919
Decitabine	Approved Investigational	CIDEA	1149	upregulated	decitabine results in increased expression of CIDEA mRNA	18p11.21	A21950
Decitabine	Approved Investigational	CITED1	4435	upregulated	decitabine results in increased expression of CITED1 mRNA	Xq13.1	A21915
Decitabine	Approved Investigational	CLCF1	23529	upregulated	decitabine results in increased expression of CLCF1 mRNA	11q13.2	A20985
Decitabine	Approved Investigational	CLDN2	9075	upregulated	decitabine results in increased expression of CLDN2 mRNA	Xq22.3	A21942
Decitabine	Approved Investigational	CLDN3	1365	upregulated	decitabine results in increased expression of CLDN3 mRNA	7q11.23	A21919 A21951
Decitabine	Approved Investigational	CLEC2B	9976	downregulated	decitabine results in decreased expression of CLEC2B mRNA	12p13.31	A20985
Decitabine	Approved Investigational	CLU	1191	upregulated	decitabine results in increased expression of CLU mRNA	8p21.1	A21952
Decitabine	Approved Investigational	CNR1	1268	upregulated	decitabine results in increased expression of CNR1 mRNA	6q15	A21953
Decitabine	Approved Investigational	CNR2	1269	upregulated	decitabine results in increased expression of CNR2 mRNA	1p36.11	A21953
Decitabine	Approved Investigational	CNTRL	11064	downregulated	decitabine results in decreased expression of CNTRL mRNA	9q33.2	A21913
Decitabine	Approved Investigational	COL14A1	7373	upregulated	decitabine results in increased expression of COL14A1 mRNA	8q24.12	A20985
Decitabine	Approved Investigational	COL17A1	1308	upregulated	decitabine results in increased expression of COL17A1 mRNA	10q25.1	A21915
Decitabine	Approved Investigational	COL1A1	1277	upregulated	decitabine results in increased expression of COL1A1 mRNA	17q21.33	A21954
Decitabine	Approved Investigational	COL1A2	1278	upregulated	decitabine results in increased expression of COL1A2 mRNA	7q21.3	A21954
Decitabine	Approved Investigational	COL8A2	1296	upregulated	decitabine results in increased expression of COL8A2 mRNA	1p34.3	A21915
Decitabine	Approved Investigational	CPA3	1359	upregulated	decitabine results in increased expression of CPA3 mRNA	3q24	A20985
Decitabine	Approved Investigational	CRISP2	7180	upregulated	decitabine results in increased expression of CRISP2 mRNA	6p12.3	A21955
Decitabine	Approved Investigational	CROCC	9696	upregulated	decitabine results in increased expression of CROCC mRNA	1p36.13	A20985
Decitabine	Approved Investigational	CSNK2A1	1457	upregulated	decitabine results in increased expression of CSNK2A1 mRNA	20p13	A21956
Decitabine	Approved Investigational	CSNK2A2	1459	upregulated	decitabine results in increased expression of CSNK2A2 mRNA	16q21	A21956
Decitabine	Approved Investigational	CST6	1474	upregulated	decitabine results in increased expression of CST6 mRNA	11q13.1	A21915

Displaying entries 29476 - 29500 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability